IL1RAP and acute myeloid leukemia: IL-RAP cell surface expression decrease was also shown on primary blasts (low and high IL-1RAP expressers, n = 6) from AML patients, with a clear difference in high IL-1RAP expressers compared to low IL-1RAP expressers (Fig. 1d, lower).